Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 35.55
-1.10 (-3.00%)
At close: Aug 7, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 3.92 billion as of August 7, 2026.
Market Cap
3.92B
Enterprise Value
3.49B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
35.55
ChartMarket Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has decreased from 4.62B to 3.92B, a decrease of -15.16%. That is a compound annual growth rate of -20.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 3.80B | -8.85% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 28.05B |
| HanchorBio | 19.99B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.94B |
| Intelligene | 6.82B |
| Uwell Biopharma | 6.75B |
| Tripartite Therapeutics | 5.29B |
| Pet Pharm Biotech | 2.77B |
| BIONET Therapeutics | 2.10B |